HOME >> BIOLOGY >> NEWS
Small molecules used to block proteins in HIV

WEST LAFAYETTE, Ind. -- Taking a cue from the Biblical story of David and Goliath, Purdue University scientists are using small molecules to bring down the molecular giants responsible for viral replication in AIDS.

The new approach blocks the interaction of two identical proteins that make up HIV protease by strategically slinging small molecules between key segments on the proteins as they come together to form an enzyme needed for viral replication. HIV protease is one of three essential enzymes used by the AIDS virus to replicate.

By targeting the site where the proteins come together, the small molecules can serve as a "molecular wedge" to prevent the proteins from interacting, thus thwarting the chain of chemical reactions needed to replicate, says Jean Chmielewski (she-ma-LEW-ski), associate professor of chemistry at Purdue who is a pioneer in the new approach.

"Theoretically, if you can stop the proteins from coming together and performing their biological activity, you'll stop viral replication," she says.

The method is currently being tested at the National Institutes of Health in cells infected with HIV, the virus that causes AIDS. If the studies prove successful, the general approach may someday be used to treat a wide range of diseases and disorders, including some currently untreatable conditions such as autoimmune diseases.

"At this stage, we've been able to synthesize some fairly potent small-molecule inhibitors of HIV protease, which do, in fact, block the ability of this enzyme to come together," Chmielewski says. "That, in turn, blocks its biological activity."

Chmielewski will present details of the new method Sunday (8/20) at the American Chemical Society's national meeting in Washington, D.C.

The new approach is based on the fact that an individual protein usually must work in conjunction with other proteins to carry out vital functions within a cell.

"There are a lot of disease states that are perpetuated b
'"/>

Contact: Susan Gaidos
sgaidos@uns.purdue.edu
765-494-2081
Purdue University
19-Aug-2000


Page: 1 2 3

Related biology news :

1. Small, Smac-like molecule encourages death of cancer cells
2. Small animal imaging gives cancer clues
3. Small RNA surmounts large cancer problem
4. Small, cold, & hungry: Ultra-small microbes from 120,000-year-old glacier ice sample
5. Small trial shows daclizumab add-on therapy improves MS outcome
6. Small gene changes in some leukemia patients may explain varying responses to chemotherapy
7. Small amounts of alcohol or anesthetics may damage the developing brain
8. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
9. Small-molecule inhibitors of anthrax lethal factor identified
10. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
11. Small-molecule inhibitors of botulinum neurotoxin identified

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... Rigaku ... the next event in a series of TOPIQ webinars, which will cover the ... webinars was developed in response to social distancing measures that resulted in postponements ...
(Date:6/19/2020)... ... June 18, 2020 , ... ... Your Lab with Software for Data Decisions,” for pharmaceutical and biotech executives, ... integrate and automate cutting-edge scientific instruments and laboratory equipment from dozens of ...
(Date:6/11/2020)... ... June 08, 2020 , ... Cryo-Cell International’s announcement ... to protect workers in the medical field. The face masks will be distributed ... their lives every day to provide healthcare to pregnant women. The delivery of ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... ... therapy for treating cancer, today announced the company has entered a license agreement ... The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the ... today that Derek Fournier has been appointed CEO and President. Founder and former ... immediately. , “DeCurtis Corporation has been on an incredible journey for the ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... today announced that it has filed an Investigational New Drug application (IND) with ... trial of its lead drug candidate NBTX-001 in patients with panic disorder (PD). ...
(Date:6/11/2020)... (PRWEB) , ... June 09, 2020 , ... ... of Phase I of a Small Business Innovation Research (SBIR) program funded by ... 21st Century: Rapid Toxin Detection in the Field”. The project’s goal was to ...
Breaking Biology Technology:
Cached News: